Home
/
Gut Health

Faecalicatena faecis: Measuring One Anaerobic Fermenter in Your Colon

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
November 4, 2025
Last updated
June 4, 2026
Key takeaway:

Measures the abundance of the gut bacterium Faecalicatena faecis to reveal microbiome imbalances. Such imbalances have been linked in research to digestive and metabolic issues, so identifying them can help you and your clinician target interventions to reduce related risks.

Read more →
Table of contents

Measuring one anaerobic fermenter in your colon

A faecalicatena faecis test measures the presence and relative abundance of a single gut bacterium in your stool. Laboratories detect it using modern DNA methods such as shotgun metagenomic sequencing (species‑level reads across the genome), 16S rRNA profiling (broader survey with limited species resolution), or targeted quantitative PCR (qPCR) for higher sensitivity to this organism. Your result is typically reported as detected/not detected and a percentage or percentile compared with a reference population. Because stool captures what’s shed from your colon, results reflect your current microbial landscape rather than a fixed trait.

What this species says about your fiber-fermenting network

Why this matters: many commensal bacteria help ferment dietary fibers into short‑chain fatty acids (SCFAs) that support gut barrier integrity, motility, and immune tone. Tracking a species like Faecalicatena faecis provides a window into that fiber‑fermenting network. While microbiome science is evolving, consistent themes hold up in studies — greater ecosystem stability and a healthy mix of beneficial fermenters are linked with more resilient digestion and lower gut inflammation, though more research is needed on species‑specific roles.

Your gut is a community, not a solo act. Single‑species tests do not diagnose disease, but they can illuminate patterns. Faecalicatena faecis is part of the anaerobic colonic community that tends to thrive when fiber intake is steady and the gut environment is calm. If this organism is consistently low or absent, it may signal a pared‑down ecosystem after antibiotics, a very low fiber pattern, or a transient shift following illness. If it’s unusually high relative to your overall diversity, that can point to a community that is out of balance — one member taking up more “space” than expected. In both directions, the signal is contextual: your symptoms, diet, medications, and other microbes matter.

This test becomes especially useful when you’re trying to make sense of persistent GI symptoms, changes after travel or antibiotics, or the impact of a new eating pattern. For example, a move from ultra‑processed foods to higher fiber often reshapes the colon’s fermentation profile over weeks, and tracking a marker species helps you see whether your gut is responding as expected. Observational research also links robust SCFA production with better barrier function and metabolic signaling, so monitoring a fermenter’s trajectory alongside stool calprotectin, CRP, or a broader microbiome panel can give a clearer story. The big picture is preventive: you’re learning how your system adapts so you and your clinician can make informed, measured adjustments rather than guessing.

Interpreting detection and abundance

Most reports show whether Faecalicatena faecis is detected and how abundant it is as a percentage of your total microbial reads, often benchmarked to a healthy reference range. Some platforms also provide a percentile versus age‑matched cohorts. There is no single “perfect” number; healthy people span a range. In general, a balanced gut features a diverse cast of fermenters and immune‑calming organisms, with no single player dominating.

If your value falls within typical ranges, it suggests your fiber‑fermenting network is present and contributing to SCFA output, which supports efficient digestion, a steadier gut barrier, and lower inflammatory signaling. If your value is low or not detected, it can reflect reduced microbial diversity, a recent course of antibiotics, low intake of fermentable fibers, or simply normal personal variation. If your value is relatively high, it may indicate an ecosystem tilt where this species occupies more niche space than expected — something to interpret alongside overall diversity and symptoms, not a diagnosis.

How to weigh a Faecalicatena faecis number in real life

Remember the context: stool water content, recent meals, bowel timing, and the test method can shift numbers day to day. 16S surveys can under‑ or over‑call species, whereas qPCR and shotgun metagenomics tend to be more specific. That’s why the most meaningful insights come from combining this result with your history and other biomarkers, then tracking trends over time. Used this way, a Faecalicatena faecis test helps personalize your path to steadier digestion, better energy, and long‑term gut resilience without overreading a single data point.

FAQs

The Faecalicatena faecis test analyzes the genetic material (DNA/RNA) of bacteria, fungi, and other microorganisms in a stool sample to identify which species are present, their diversity, relative abundance, and the community’s functional potential (for example metabolic pathways and gene functions).

Results describe the microbial composition and balance of the gut ecosystem—showing diversity and relative over‑ or under‑representation of taxa and functional capabilities—but do not by themselves diagnose specific diseases or confirm clinical conditions.

The Faecalicatena faecis test is a simple at‑home stool collection: the kit contains a small swab or a tiny vial—use the swab to collect a small amount of stool or transfer a pea‑sized sample into the provided vial, following the kit’s step‑by‑step instructions. Most kits include a disposable applicator, a leak‑proof transport tube, and a biohazard bag for return shipping; do the collection on a clean surface and avoid contaminating the sample with urine or water.

Maintain strict cleanliness, clearly label the sample with your name and the date as instructed, and complete any required paperwork. Following the kit directions exactly (amount to collect, sealing, storage temperature, and prompt shipping) is essential to preserve DNA quality and ensure accurate sequencing results.

Faecalicatena faecis test results—specifically the presence and relative abundance of this organism—can offer insights into how your gut ecosystem is functioning, including aspects of digestion (for example microbial fermentation activity), levels of intestinal inflammation, how well nutrients may be being absorbed, influences on host metabolism, and signals that contribute to gut–brain communication.

These patterns can correlate with certain physiological states or risks but do not by themselves diagnose specific diseases; accurate interpretation requires clinical context, corroborating tests, and discussion with a healthcare provider or microbiome specialist.

Test results represent a snapshot in time and can change with recent diet, stress, bowel transit time or recent antibiotic use (which can suppress or alter abundances), so repeat sampling or clinical correlation is often needed to interpret findings accurately.

Many people test their faecalicatena faecis once per year to establish a baseline, and more frequently—about every 3–6 months—when actively adjusting diet, probiotics, medications, or other interventions to monitor responses.

Focus on trends over time rather than single readings: repeated measurements reveal direction and magnitude of change, while one-off results can reflect short-term variation and are less informative for guiding long‑term decisions.

Yes — microbial populations, including Faecalicatena faecis, can shift noticeably within days in response to diet, antibiotics, illness, travel or other lifestyle changes, but more consistent, stable community patterns typically emerge over weeks to months.

For meaningful comparisons or to track true baseline changes, keep diet and lifestyle as consistent as possible for several weeks before retesting, since short-term fluctuations may not reflect long-term trends.

References

  1. Sakamoto, M., Iino, T., & Ohkuma, M. (2017). Faecalimonas umbilicata gen. nov., sp. nov., isolated from human faeces, and reclassification of Eubacterium contortum, Eubacterium fissicatena and Clostridium oroticum as Faecalicatena contorta gen. nov., comb. nov., Faecalicatena fissicatena comb. nov. and Faecalicatena orotica comb. nov. International Journal of Systematic and Evolutionary Microbiology, 67(5), 1219-1227. https://doi.org/10.1099/ijsem.0.001790
  2. Vacca, M., Celano, G., Calabrese, F. M., Portincasa, P., Gobbetti, M., & De Angelis, M. (2020). The controversial role of human gut Lachnospiraceae. Microorganisms, 8(4), 573. https://doi.org/10.3390/microorganisms8040573
  3. Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Frontiers in Immunology, 10, 277. https://doi.org/10.3389/fimmu.2019.00277
  4. Laudadio, I., Fulci, V., Palone, F., Stronati, L., Cucchiara, S., & Carissimi, C. (2018). Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. OMICS, 22(4), 248-254. https://doi.org/10.1089/omi.2018.0013
  5. Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., & Aadil, R. M. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Frontiers in Microbiology, 13, 999001. https://doi.org/10.3389/fmicb.2022.999001

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey